Marta P. Nascimento
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marta P. Nascimento has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra M. L. Oliveira
NOVA Medical School, Faculdade de Ciências Médicas (NMS, FCM), Universidade Nova de Lisboa, 1160-056 Lisboa, Portugal
2 shared publications - Diogo B. Bitoque
NOVA Medical School, Faculdade de Ciências Médicas (NMS, FCM), Universidade Nova de Lisboa, 1160-056 Lisboa, Portugal
2 shared publications - Gabriela Araujo Silva
NOVA Medical School, Faculdade de Ciências Médicas (NMS, FCM), Universidade Nova de Lisboa, 1160-056 Lisboa, Portugal
2 shared publications - Luís Abegão Pinto
Ophthalmology Department, Centro Hospitalar Universitário de Lisboa Norte, 1649-035 Lisboa, Portugal
2 shared publications - Mafalda Guerreiro
NOVA Medical School, Faculdade de Ciências Médicas (NMS, FCM), Universidade Nova de Lisboa, 1160-056 Lisboa, Portugal
2 shared publications - Maria Raposo
Laboratory for Instrumentation, Biomedical Engineering and Radiation Physics (LIBPhys-UNL), Associated Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Department of Physics, NOVA School of Science and Technology, NOVA University of Lisbon, Campus FCT-UNL, 2829-516 Caparica, Portugal
2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (18) , 8257
From Fabrication to Function: Scalable Spray-Assisted Layer-by-Layer Films for Drug Delivery in Glaucoma
Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibroblast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces intended to enable localized release of antiproliferative agents, as a proof-of-concept approach toward more standardized patient care. Multilayer thin films composed of poly(β-amino ester) (PBAE) and a 5-fluorouracil (5-FU) and β-cyclodextrin (β-CD) complex (5-FU:β-CD) were fabricated, without (type A films) and with (type B films) graphene oxide (GO) barrier layers. Film growth was monitored by ultraviolet–visible spectroscopy (UV-Vis) and vacuum ultraviolet spectroscopy (VUV), confirming consistent, sequential deposition; type A films exhibited lower variability than GO-containing type B films. Drug release studies revealed a rapid burst release within the first 5 min, followed by a plateau, regardless of GO incorporation, indicating that sustained drug release was not achieved under the current film architecture. Cell cycle analysis confirmed that β-CD complexation preserved the biological activity of 5-FU, which induced an S-phase arrest in a dose-dependent manner. Although further optimization of film architecture and composition is required to improve release control and achieve sustained delivery, this study demonstrates the feasibility of spray-assisted LbL coatings as a localized drug delivery strategy for GDD surfaces. Overall, these findings support the proof-of-concept nature of this approach and identify key parameters that must be optimized before translational applicability can be established.
- 16 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (18) , 8257
Open AccessFrom Fabrication to Function: Scalable Spray-Assisted Layer-by-Layer Films for Drug Delivery in Glaucoma
Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibroblast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces intended to enable localized release of antiproliferative agents, as a proof-of-concept approach toward more standardized patient care. Multilayer thin films composed of poly(β-amino ester) (PBAE) and a 5-fluorouracil (5-FU) and β-cyclodextrin (β-CD) complex (5-FU:β-CD) were fabricated, without (type A films) and with (type B films) graphene oxide (GO) barrier layers. Film growth was monitored by ultraviolet–visible spectroscopy (UV-Vis) and vacuum ultraviolet spectroscopy (VUV), confirming consistent, sequential deposition; type A films exhibited lower variability than GO-containing type B films. Drug release studies revealed a rapid burst release within the first 5 min, followed by a plateau, regardless of GO incorporation, indicating that sustained drug release was not achieved under the current film architecture. Cell cycle analysis confirmed that β-CD complexation preserved the biological activity of 5-FU, which induced an S-phase arrest in a dose-dependent manner. Although further optimization of film architecture and composition is required to improve release control and achieve sustained delivery, this study demonstrates the feasibility of spray-assisted LbL coatings as a localized drug delivery strategy for GDD surfaces. Overall, these findings support the proof-of-concept nature of this approach and identify key parameters that must be optimized before translational applicability can be established.
- Open Access
- 14 August 2026
- Published by MDPI AG in Preprints.org
From Fabrication to Function: Scalable Spray-Assisted Layer-by-Layer Films for Drug Delivery in Glaucoma
Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibro-blast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces that enables localized release of antiproliferative agents, aiming to standardize patient care. Multilayer thin films composed of poly(β-amino ester) (PBAE) and a 5-fluorouracil (5-FU) and β-cyclodextrin (β-CD) complex (5-FU:β-CD) were fabricated, without (type A films) and with (type B films) graphene oxide (GO) barrier layers. Film growth was monitored by ultraviolet–visible spectroscopy (UV-Vis) and vacuum ultraviolet spectroscopy (VUV), confirming consistent, sequential deposition; type A films exhibited greater reproducibility than GO-containing type B films. Drug release studies revealed a rapid burst release within the first 5 min, fol-lowed by a plateau, regardless of GO incorporation. Cell cycle analysis confirmed that β-CD complexation preserved the biological activity of 5-FU, which induced an S-phase arrest in a dose-dependent manner. Although further optimization of film archi-tecture and composition is required to achieve sustained release, this study demon-strates the feasibility of spray-assisted LbL coatings as a localized drug delivery strate-gy for GDD surfaces. Overall, these findings establish a promising platform for the fu-ture development of more effective and standardized coatings for glaucoma surgical devices.
- 14 August 2026
- Published by MDPI AG in Preprints.org
Open AccessFrom Fabrication to Function: Scalable Spray-Assisted Layer-by-Layer Films for Drug Delivery in Glaucoma
Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibro-blast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces that enables localized release of antiproliferative agents, aiming to standardize patient care. Multilayer thin films composed of poly(β-amino ester) (PBAE) and a 5-fluorouracil (5-FU) and β-cyclodextrin (β-CD) complex (5-FU:β-CD) were fabricated, without (type A films) and with (type B films) graphene oxide (GO) barrier layers. Film growth was monitored by ultraviolet–visible spectroscopy (UV-Vis) and vacuum ultraviolet spectroscopy (VUV), confirming consistent, sequential deposition; type A films exhibited greater reproducibility than GO-containing type B films. Drug release studies revealed a rapid burst release within the first 5 min, fol-lowed by a plateau, regardless of GO incorporation. Cell cycle analysis confirmed that β-CD complexation preserved the biological activity of 5-FU, which induced an S-phase arrest in a dose-dependent manner. Although further optimization of film archi-tecture and composition is required to achieve sustained release, this study demon-strates the feasibility of spray-assisted LbL coatings as a localized drug delivery strate-gy for GDD surfaces. Overall, these findings establish a promising platform for the fu-ture development of more effective and standardized coatings for glaucoma surgical devices.